TANG CAPITAL PARTNERS LP 13D and 13G filings for CytomX Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:00 pm Purchase | 2023-12-31 | 13G | CytomX Therapeutics, Inc. CTMX | TANG CAPITAL PARTNERS LP | 6,550,000 9.800% | 3,039,555 (+86.59%) | Filing |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | CytomX Therapeutics, Inc. CTMX | TANG CAPITAL PARTNERS LP | 3,510,445 5.300% | 39,545 (+1.14%) | Filing |
| 2022-07-25 4:00 pm Purchase | 2022-07-15 | 13G | CytomX Therapeutics, Inc. CTMX | TANG CAPITAL PARTNERS LP | 3,470,900 5.300% | 3,470,900 (New Position) | Filing |